Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RENEWI PLC Director's Dealing 2018

Dec 3, 2018

4694_dirs_2018-12-03_35a56acb-0fe7-4d2b-8844-4bba74701838.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1336J

Renewi PLC

03 December 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Colin Matthews

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renewi plc

b)

LEI

213800CNEIDZBL17KU22

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB007995243

b)

Nature of the transaction

Market Purchase

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.40 100,000

d)

Aggregated information

- Aggregated volume

- Price

100,000

£0.40

e)

Date of the transaction

30 November 2018

f)

Place of the transaction

London Stock Exchange

Contact

Philip Griffin-Smith

Group Company Secretary 01908 650586

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBRBDBCSXBGIG